Does Stripe allow peptide sales? What RUO suppliers need to know

Stripe's Prohibited and Restricted Businesses policy is the rulebook every Stripe-connected business agrees to. Among other things, it prohibits the sale of unapproved pharmaceuticals and products marketed for human consumption or use without the required regulatory approval, and it restricts categories that carry elevated regulatory or card-network exposure.

A peptide sold to an individual, with dosing guidance and a physiological claim, is a product marketed for human use without approval. The Research Use Only label on the page does not change that. It is the presentation, the buyer and the use that matter, and Stripe, the acquiring banks and the card networks all read the whole storefront, not just the disclaimer.

In practice, consumer-facing peptide storefronts on Stripe are identified and shut down, often with funds held and a report to the networks. Suppliers that genuinely serve research institutions can operate within the policy, but only when the entire operation, from catalog to checkout to fulfillment, is consistent with research supply.

Stripe's rules sit on top of the card-network rules. Mastercard's Business Risk Assessment and Mitigation program and Visa's Integrity Risk Program exist to find and penalize illegal or brand-damaging transactions in the system. When a merchant sells a prohibited product, the fine lands on the acquirer and processor first and is passed down the chain. These fines are large, they are assessed per violation, and the merchant's principals can end up on the Mastercard MATCH list, which other acquirers consult before boarding anyone.

This is why a peptide storefront that is quietly breaking the rules is not a small problem for a processor. It is an open liability with a six-figure ceiling.

NoRamp is payments infrastructure built on Stripe. Stripe is the processor of record, and Stripe's policy is our floor. We add our own Research Use Only policy on top of it, and ours is stricter in every direction: no prescription compound under any name, no human-use positioning anywhere, no consumer formats, no sales to individuals, no injection supplies, and no prior terminations or regulatory history of any kind.

The plain consequence: if you could not pass Stripe's review, you will not pass ours. If you were terminated by Stripe, you will not pass ours either. We do not exist to board merchants Stripe will not take. We exist to serve the research suppliers Stripe would take, with a platform that invests in them and a review process that keeps the category clean.

• If your customers are individuals, there is no compliant way to process their peptide purchases through Stripe or through NoRamp. We will decline, and we will not help you find a processor that will not.
• If your customers are institutions and credentialed labs, and your storefront, checkout and order patterns reflect that, you can be approved. Read the storefront standard and the application review, then apply.
• If you are not sure which one you are, you are the first one.